Skip to main content
. 2016 Jan 11;11(3):1104–1108. doi: 10.3892/etm.2016.2980

Figure 3.

Figure 3.

Changes in sputum endothelin (ET)-1 level in patients under anti-tuberculosis (TB) chemotherapy. Patients with active pulmonary TB were treated with a weight-adjusted fixed-dose of Rifafour e-275. Changes in the sputum ET-1 level (pg/ml) from baseline (day 0) on days 1, 2, 4, 6, 10 and 14 were expressed as ΔSputum ET-1 and plotted against the time.